A Clinical Trial to Assess the Elixir Medical LithiX Coronary Hertzian Contact Intravascular Lithotripsy Catheter

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 27, 2023

Primary Completion Date

March 29, 2024

Study Completion Date

September 9, 2024

Conditions
Coronary Artery Disease
Interventions
DEVICE

LithiX Coronary Hertzian Contact Intravascular Lithotripsy Catheter (LithiX Coronary HCIVLC; LithiX)

Vessel preparation of moderately to severely calcified coronary artery lesions prior to stenting allows for full stent expansion and apposition to the vessel wall

Trial Locations (7)

Unknown

ZNA Middelheim, Antwerp

Ziekenhuis Oost-Limburg, Campus Sint Jan, Genk

Jessa Ziekenhuis, Hasselt

Universitaire Ziekenhuizen Leuven, Leuven

Meander Medical Centre, Amersfoort

Catharina Ziekenhuis, Eindhoven

Maasstad Ziekenhuis, Rotterdam

Sponsors
All Listed Sponsors
lead

Elixir Medical Corporation

INDUSTRY

NCT05828173 - A Clinical Trial to Assess the Elixir Medical LithiX Coronary Hertzian Contact Intravascular Lithotripsy Catheter | Biotech Hunter | Biotech Hunter